CV: ARRHYTHMIAS, ECG changes.
GI: abdominal pain, diarrhea, flatulence, nausea, vomiting.
tablets, capsules only: GI ulceration, stenotic lesions.
Neuro: paralysis, paresthesia , confusion, restlessness, weakness.
Potassium Bicarbonate/Potassium Chloride
- Tablets for effervescent oral solution: 25 mEq;
Potassium Chloride
(generic available)
- Extended-release capsules: 8 mEq; 10 mEq;
- Extended-release tablets: 8 mEq; 10 mEq; 15 mEq; 20 mEq;
- Oral solution: 20 mEq/15 mL; 40 mEq/15 mL;
- Powder for oral solution: 20-mEq/packet;
Expressed as mEq of potassium. Potassium bicarbonate contains 10 mEq potassium/g; potassium chloride contains 13.4 mEq potassium/g
Normal Daily Requirements
- PO (Adults): 40–80 mEq/day.
- PO (Children): 2–3 mEq/kg/day.
- PO (Neonates): 2–6 mEq/kg/day.
Prevention of Hypokalemia During Diuretic Therapy
- PO (Adults): 20–40 mEq/day in 1–2 divided doses; single dose should not exceed 20 mEq.
- PO (Neonates , Infants and Children): 1–2 mEq/kg/day in 1–2 divided doses.
Treatment of Hypokalemia
- PO (Adults): 40–100 mEq/day in divided doses.
- PO (Neonates , Infants and Children): 2–5 mEq/kg/day in divided doses.
Potassium Chloride: Klor-Con, Klor-Con M10, Klor-Con M15, Klor-Con M20, K-Tab, Slow-K
Therapeutic Classification: mineral and electrolyte replacements/supplements
Absorption: Well absorbed following oral administration.
Distribution: Enters extracellular fluid; then actively transported into cells.
Metabolism/Excretion: Excreted by the kidneys.
Half-life: Unknown.
Potassium Chloride: Micro-K
(↑ in serum potassium levels)